Celebrating #WorldDiabetesDay2026 through community outreach, patient empowerment, training young minds for better diabetes care, and interdisciplinary collaboration.
Beyond hospital walls towards accessible, and inclusive diabetes care.@IndiaESI @Rssdi_official @IntDiabetesFed
13
334
World Diabetes Day at RGCDE, AMU!
100 people living with Type 1 Diabetes participated in a unique programme planned and conducted by our patients themselves!
Painting competition held. School bags & glucometers distributed
A celebration of confidence, creativity & empowerment!
Diabetes care begins with awareness, but meaningful change comes through action!
Delighted to join the ESI expert panel for “Diabetes Made Simple: From Awareness to Action.”
📅 7 Nov | 4:30 PM
📍 Facebook LIVE
facebook.com/events/16779031…
1
74
Taking Diabetes Care Beyond Hospital Walls!
Successfully concluded RSSDI Village Adoption & Diabetes Distilled CME at AMU.
150 patients screened, 150 delegates!
Grateful to Prof. Verma & Dr. Tewari. Special thanks to Salman Shah, Rehan, Dr. Ahmad & our team!
@Rssdi_official
8
238
Could wireless technology transform diabetes and obesity care?
A fascinating study explores an electrocatalytic closed-loop system for drug-free management of diabesity.
Early-stage research, but an exciting glimpse into the future of metabolic medicine!
What if we treated high glucose not by giving a drug, but by removing glucose itself?
A study in Science this week describes ECHO, an implantable device designed to do exactly that, without insulin and without medication.
How it works:
The implant sits under the skin and contains an electrocatalyst made of platinum decorated gold nanoclusters embedded in porous graphite.
When wirelessly powered at low power (0.75 volts), the catalyst selectively converts blood glucose into gluconate. Gluconate carries less energy and is cleared by the kidneys into the urine, so both glucose and calories leave the body.
Because the reaction is driven electrically, the rate of glucose removal is adjustable. Turn the current up, remove glucose faster. Turn it off, removal stops.
The closed loop comes from pairing it with a standard continuous glucose monitor. The CGM detects glucose above a set threshold, the implant activates, glucose falls, and the system switches off. In this study it was also smartphone controlled.
What happened in mice with type 2 diabetes and obesity:
Glucose returned to the normal range within 1 hour of activation. Repeated treatment maintained control for 6 weeks with no detectable hypoglycemia. As glucose was removed, metabolism shifted toward fat use. Body weight and triglycerides fell, while free fatty acids and ketone bodies rose. No adverse physiological, inflammatory, or behavioral effects were detected over those 6 weeks.
This is early stage, mice only, 6 weeks of data. Human questions are unanswered: catalyst durability over years, tissue reaction to a permanent implant, kidney handling of a sustained gluconate load, and whether the glucose removal rate scales from a mouse to a human.
We already have effective human therapies with outcome data, from metformin and SGLT2 inhibitors to GLP-1 receptor agonists and automated insulin delivery. ECHO is not a replacement for any of them today.
It is a proof of concept for a different category: closed loop diabetes care that does not deliver a drug at all, but removes the substrate itself. science.org/doi/10.1126/scie…
60
Metabolic Health Summit Lucknow
lnkd.in/p/gJFYfgM5
2
66
Sarcopenic obesity in South Asians with T2DM deserves greater attention. Our new editorial highlights diagnostic gaps, the unique South Asian phenotype, and the need for affordable, region-specific screening—especially as GLP-1–based therapies expand. Preserving muscle matters!
3
182
Type 1 diabetes is insulin-dependent. Never stop insulin based on claims of a “cure” through diet or supplements. Insulin withdrawal can rapidly cause DKA—a life-threatening emergency. Vomiting, abdominal pain, deep breathing, drowsiness? Seek emergency care immediately.
🚨 Veeramachineni Ramakrishna (VRK) booked after law student ends up in hospital
Social media personality #Veeramachineni Ramakrishna (VRK) and “Dr” Koteshwara Rao have been booked by @cyberabadpolice in an alleged fake-doctor and fraud case.
A 30-year-old law student with Type-1 #diabetes alleged that he was advised to stop insulin after approaching VRK over his #VRKdiet, which he claimed was promoted as a cure for Type-1 diabetes.
Two days after stopping insulin, the student was hospitalised with diabetic ketoacidosis and severe dehydration, according to the FIR.
He alleged that he paid around ₹26,000 for supplements and services.
Police booked the accused under provisions relating to cheating, endangering human life and criminal conspiracy, along with sections of the National Medical Commission Act and Drugs and Magic Remedies Act.
The complainant has also approached the Nampally Consumer Court seeking compensation.
The allegations are based on the complaint and FIR; the investigation is ongoing.
93
Alexander Zverev’s story is a powerful reminder that children with type 1 diabetes can play sports, compete, and achieve anything.
Our responsibility is not only to manage glucose but also to remove unnecessary fears.
Manage diabetes—don’t let diabetes manage the child’s dreams
1
60
Join us tonight, 6:30–8:00 PM IST, for the 94th #EndocrinologyMasterclass.
Clinical Grand Round: "Peter Pan with a Fracture" — an intriguing case on growth, puberty & bone health, presented by DM residents nationwide.
endomasterclass-sessions.org…
@SanjayKalraDr1 @arnavk
What if GLP-1 drugs could influence ageing not just obesity and diabetes?
A new Nature study found that late life semaglutide increased median lifespan by 12% in female mice, with improvements in physical function and memory
Exciting, but mouse data, yet to established in human
What if the real benefit of weight loss is not just a healthier body, but a fuller life?
A thought-provoking Economist report explores the “obesity penalty” and suggests that GLP-1–associated weight loss may extend beyond better metabolic health to employment and relationships.
2
78
Delighted to be part of the National Symposium on “Importance of Soft Skills in Healthcare Education and Practice” at AMU today.
Because in healthcare, knowledge treats disease, but communication, empathy & counselling care for the person.
#SoftSkills #HealthcareEducation #AMU
3
91
A new PNAS study identifies MED14 phosphorylation as a key mechanism linking GLP-1 signaling to sustained β-cell genomic responses.
A fascinating insight into how incretin therapies may shape β-cell function beyond their immediate effects. doi.org/10.1073/pnas.2536772…
1
107
Like most RCTs in diabetes, vitamin D supplementation also fails to show significant benefit in colorectal cancer.
Biological plausibility ≠ clinical benefit. RCTs matter.
2
70
Like most RCTs in diabetes, vitamin D supplementation also fails to show significant benefit in colorectal cancer.
Biological plausibility ≠ clinical benefit. RCTs matter.
3
199
Pleased to share our latest publication in Haemophilia (2026), exploring the mechanisms of skeletal impairment in children with haemophilia and highlighting the potential role of the RANKL/OPG osteoclastogenic index as a biomarker of bone health.
#Haemophilia #BoneHealth
4
116
🩺 93rd Endocrinology Masterclass — TODAY
📅 21 Aug | 🕡 6:30–8:00 PM IST 🔗 endomasterclass.org
Clinical Grand Round: “The Prescription Nobody Asked About”
Join us today evening for an interesting case, presented and discussed live.
1
59
We report alpha-lipoic acid–induced Insulin Autoimmune Syndrome (IAS) causing recurrent hypoglycaemia in a non-diabetic patient, with HLA-DRB1*04:03:01G.
The case underscores the importance of asking about OTC supplements in unexplained hypoglycaemia.@bmj_latest @Rssdi_official





























